English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Roche acquired Adheron Therapeutics with $580
2015-11-25
Recently, Roche acquired Adheron Therapeutics with $580 million for enhancing the immune research. The shareholders of Adheron Therapeutics get $150 million cash, the other $475 million will be paid after they ..
NIH Earmarks $48.2M for Progenitor Cell Translational Research Consortium
2015-11-25
The National Institutes of Health announced that it will commit as much as $40 million over the next seven years to fund the creation of the National Heart, Lung, and Blood Institute Progenitor Cell Translational Cons..
Gene Expression Informatics Companies Collaborate on Diagnostics of Age-Related Diseases
2015-11-24
Affymetrix, Inc. (Santa Clara, CA, USA) and XRGenomics LTD (Nottingham, UK) have announced a partnership to collaborate on research and development of a new generation of diagnostic tests for age-related diseases. ..
Diagnostics companies jump into rapidly growing market for POC superbug tests
2015-11-24
As the number of drug-resistant superbug infections continues to rise, diagnostics companies are rolling out rapid, point-of-care devices that can quickly identify infectious bacteria and potentially cut down on the n..
In Brief This Week: Meridian Bioscience; Agilent; Alere
2015-11-24
Meridian Bioscience announced this week that the US Food and Drug Administration has cleared new claims for the firm's illumigene Pertussis molecular amplification test. The new claims include specimens collected ..
Thermo Fisher Inks Companion Dx Deal With Novartis, Pfizer
2015-11-23
Nov 18, Thermo Fisher Scientific said that it has entered into a long-term agreement with Novartis and Pfizer to develop and commercialize a multi-marker, next-generation sequencing-based companion diagnostic test. Th..
Merck KGaA Buys Sigma-Aldrich for $17B
2015-11-23
Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will "co..
Diatherix, Color Genomics Receive CAP Accreditation
2015-11-23
Diatherix Laboratories, a Eurofins subsidiary, and Color Genomics have both announced accreditation from the College of American Pathologists. To receive accreditation inspectors examined several laboratory co..
Shenzhen Kangmei Listing on The New OTC Market
2015-11-20
NOV 17,Shenzhen Kangmei Biotechnology Co., Ltd apply for list on the new OTC market. The details show’s Shenzhen Kangmei was established in Dec 29, 2007. Mr. Bi Shaohui, the chairman of Shenzhen Kangmei account..
Epic Sciences & Upenn announced collaboration to find biomarkers in circulating tumor cell
2015-11-20
Epic Sciences and the University of Pennsylvania's Abramson Cancer Center today announced a collaboration to find biomarkers in circulating tumor cells. Under the terms of the agreement, the partners will cond..
Codiak BioSciences Launches With $80M Financing to Develop Exosome-Based Products
2015-11-20
A new firm called Codiak BioSciences has secured more than $80 million in financing to create therapeutic and diagnostic products based on exosome-related technology developed at the University of Texas MD Anderson Ca..
China faces the second wave of laid-offs
2015-11-19
“The second wave of laid-offs will be invaded” spread widely recently. A senior researcher on employment at Renmin University of China, Zeng Xiangquan, said at a recent forum that the unemployed rate issue..
Mokobio Listing on The New OTC Market
2015-11-19
NOV 17, Mokobio Life Science was approved to list on the new OTC market and public transfer. The note shows, Mokobio’s revenues from January to April in 2015 is ¥3.234 million, and net profit is ¥-4.36 ..
Enzo Biochem Lands HCV Quantitative Test
2015-11-19
Enzo Biochem today announced that the New York State Department of Health has granted approval of its AmpiProbe-HCV assay for quantitative detection of Hepatitis C virus. AmpiProbe is the firm's proprietar..
Molecular Health Gets $26.8M
2015-11-18
Molecular Health said today that it has raised €25 million ($26.8 million) in a private financing round led by current investor Dievini, which it will use to continue building out its commercial platform and to d..
Total:
3209
Pages:
214
First
Prev
1
..
198
199
200
201
202
203
204
..
214
Next
End